Skip to main content

EDITORIAL article

Front. Cardiovasc. Med.
Sec. Cardiovascular Biologics and Regenerative Medicine
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1477927
This article is part of the Research Topic Methods in Cardiovascular Biologics and Regenerative Medicine View all 9 articles

Editorial: Methods in cardiovascular biologics and regenerative medicine

Provisionally accepted
Narasimman Gurusamy Narasimman Gurusamy 1*Olaf Bergmann Olaf Bergmann 2,3,4Clotilde Castaldo Clotilde Castaldo 5Ngan F. Huang Ngan F. Huang 6,7Ching-Ling (Ellen) Lien Ching-Ling (Ellen) Lien 8Jun Jie Tan Jun Jie Tan 9Felix B. Engel Felix B. Engel 10
  • 1 Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States
  • 2 Department of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Lower Saxony, Germany
  • 3 Department of Cell and Molecular Biology, Karolinska Institutet (KI), Stockholm, Stockholm, Sweden
  • 4 DZHK (German Centre for Cardiovascular Research), partner site Lower Saxony, Lower Saxony, Germany
  • 5 Department of Public Health, School of Medicine and Surgery, University of Naples Federico II, Naples, Campania, Italy
  • 6 Department of Cardiothoracic Surgery, School of Medicine, Stanford University, Stanford, California, United States
  • 7 VA Palo Alto Health Care System, Veterans Health Administration, United States Department of Veterans Affairs, Palo Alto, California, United States
  • 8 Departments of Surgery, Biochemistry, and Molecular Medicine, Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
  • 9 USM-ALPS Laboratory for Heart Research, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia
  • 10 Experimental Renal and Cardiovascular Research, Department of Nephropathology, Institute of Pathology and Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany

The final, formatted version of the article will be published soon.

    Keywords: methods in cardiovascular biologics, Regenerative Medicine, Tissue Engineering, Pericytes, cardiac remuscularization, 3D-bioprinting, vascular grafts, Mitochondrial function

    Received: 08 Aug 2024; Accepted: 26 Aug 2024.

    Copyright: © 2024 Gurusamy, Bergmann, Castaldo, Huang, Lien, Tan and Engel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Narasimman Gurusamy, Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.